HCPCS Code J7613 is used to report the administration of albuterol in a unit dose format, specifically 3 mL per unit. Albuterol is a short-acting beta-2 adrenergic agonist commonly used for the treatment or prevention of bronchospasm in conditions such as asthma, chronic obstructive pulmonary disease (COPD), and other respiratory disorders. This code is typically used for billing the drug when delivered via nebulizer in a clinical or hospital setting.
Key Facts About HCPCS J7613
Service type: Drug administration (unit dose)
Provider type: Physicians, respiratory therapists, and other qualified healthcare professionals
Drug type: Albuterol (short-acting beta-2 agonist)
Unit of measure: 3 mL per unit
Route of administration: Nebulized inhalation
Common clinical indications:
- Acute asthma exacerbation
- Chronic obstructive pulmonary disease (COPD) flare-ups
- Exercise-induced bronchospasm
- Bronchospasm associated with other pulmonary conditions
- Preventive use in patients at risk of acute bronchospasm
When to Use HCPCS J7613
HCPCS J7613 is appropriate when:
- Albuterol is administered in a unit dose of 3 mL
- The administration occurs in a clinical setting via nebulizer
- The service is medically necessary for relief or prevention of bronchospasm
- Documentation includes the amount and method of administration
Examples:
- Nebulized albuterol administered to a patient experiencing an asthma attack
- Albuterol treatment during an acute COPD exacerbation in a hospital or clinic
- Preventive nebulized albuterol for exercise-induced bronchospasm
- Administration of albuterol for a patient with acute bronchospasm in a pediatric clinic
Documentation Requirements
To support HCPCS J7613 billing, documentation should include:
- Patient identifiers and date of service
- Clinical indication for albuterol administration
- Dose and total volume administered (e.g., 3 mL per unit)
- Route of administration (nebulized inhalation)
- Number of units administered
- Provider credentials and signature
- Patient response to treatment
Complete documentation ensures compliance, supports reimbursement, and facilitates continuity of care.
Reimbursement and Coding Considerations
- HCPCS J7613 is reimbursed per 3 mL unit dose administered
- Coverage may vary depending on payer and clinical indication
- Multiple units should be reported separately based on the volume administered
- Proper documentation must support the medical necessity of albuterol therapy
- Verify payer-specific guidelines for nebulized drug reimbursement
Accurate coding and documentation help ensure proper reimbursement and reduce claim denials.
How OptiMantra Supports Albuterol Administration
OptiMantra’s integrated EMR and practice management system streamlines documentation and billing for HCPCS J7613:
With OptiMantra, providers can:
- Record albuterol administration details, including unit dose and total volume
- Document clinical indication and patient response
- Track medication administration across multiple visits within the longitudinal record
- Link medication administration to diagnoses and care plans
- Support compliant, audit-ready billing codes for unit dose albuterol
By centralizing drug administration documentation and billing, OptiMantra helps practices improve efficiency, maintain compliance, and optimize reimbursement.
Try OptiMantra for free here!
Disclaimer: CPT® codes are maintained by the American Medical Association. This guide is for informational purposes only and does not replace official coding guidelines or payer policies.
.png)
